Drug-Device comboLaserStock , not too long ago you wrote about a drug-device combo that could potentially get a conditional nod from the FDA . I was wondering if this would be faster to market than completing a Ph 2 ? You might not have definitive answers to this possible strategic corporate direction TLT could take but any elaboration would be appreciated . Anybody else can chime in also . CHEERS